NUK - logo
E-resources
Full text
Peer reviewed Open access
  • Osteoporosis and sarcopenia...
    Hata, Ryosuke; Miyamoto, Kana; Abe, Yukiko; Sasaki, Takashi; Oguma, Yuko; Tajima, Takayuki; Arai, Yasumichi; Matsumoto, Morio; Nakamura, Masaya; Kanaji, Arihiko; Miyamoto, Takeshi

    Bone, January 2023, 2023-01-00, 20230101, Volume: 166
    Journal Article

    It is mandatory to manage musculoskeletal disorders in the elderly to prevent their becoming bed-ridden or requiring long-term care. However, the prevalence of musculoskeletal disorders such as osteoporosis and sarcopenia in otherwise healthy people over 85 years old is not completely known. Here we enrolled 1026 healthy subjects between 85 and 89 years old and evaluated them for the presence of osteoporosis, sarcopenia and fragility fracture(s), and how those conditions were related. We also evaluated biomarkers such as serum levels of insulin-like growth factor 1 (IGF1) and vitamin D status. The prevalence of osteoporosis, sarcopenia or fragility fracture(s) in these subjects was 22.4, 10.2 or 15.0 %, respectively. Serum IGF1 and 25(OH)D were significantly and negatively correlated with osteoporosis or sarcopenia. Osteoporosis and either sarcopenia or fragility fracture(s) were significantly related and shown to be risk factors for each other, even after adjustment for gender and BMI, while sarcopenia and fragility fracture(s) were not associated. Our data may provide a health platform for the very elderly and suggest strategies to prevent musculoskeletal disorders in this population. •Osteoporosis and sarcopenia are associated in very old elderly people.•Osteoporosis and fragility fracture(s) are associated in very old elderly people.•Reduced IGF1 levels is a risk for osteoporosis in very old elderly people.•Reduced IGF1 levels is a risk for sarcopenia in very old elderly people.